Click Here to reset your filters.
REGISTRATION
Category: Neuroscience
Type of Molecule: Small Molecule
REGISTRATION
Category: GI / Internal Medicine
Type of Molecule: Small Molecule
* Program has completed phase 3/ pivotal trials and is awaiting further regulatory action
REGISTRATION
Category: Ophthalmics
Type of Molecule: Small Molecule
Phase II
Category: GI / Internal Medicine
Type of Molecule: Protein
Rare indication
* SHP607 originally studied for ROP
Phase II
Category: Neuroscience
Type of Molecule: Small Molecule
Phase III
Category: Neuroscience
Type of Molecule: Small Molecule
Phase III
Category: Immunology
Type of Molecule: Protein
Rare indication
Phase III
Category: Immunology
Type of Molecule: Protein
Rare indication
2018 Approvals
Category: Immunology
Type of Molecule: Protein
Rare indication
Phase III
Category: Immunology
Type of Molecule: Protein
Rare indication
Phase III
Category: Immunology
Type of Molecule: Small Molecule
Rare indication
* Granted breakthrough designation by FDA
Phase III
Category: GI / Internal Medicine
Type of Molecule: Small Molecule
Rare indication
* Granted breakthrough designation by FDA
Learn more at ShireTrials.com
Phase I
Category: Genetic Diseases
Type of Molecule: Protein
Rare indication
Phase III
Category: GI / Internal Medicine
Type of Molecule: Peptide
Rare indication
Phase III
Category: GI / Internal Medicine
Type of Molecule: Peptide
Rare indication
Phase I
Category: GI / Internal Medicine
Type of Molecule: Therapeutic Protein
Rare Indication
Phase I
Category: Ophthalmics
Type of Molecule: Peptide
Phase III
Category: Ophthalmics
Type of Molecule: Small Molecule
REGISTRATION
Category: Immunology
Type of Molecule: Antibodies (and derivatives)
Rare indication
2018 Approvals
Category: Immunology
Type of Molecule: Antibodies (and derivatives)
* Granted breakthrough designation by FDA
Phase III
Category: GI / Internal Medicine
Type of Molecule: Antibodies (and derivatives)
Phase III
Category: GI / Internal Medicine
Type of Molecule: Antibodies (and derivatives)
Phase II
Category: Immunology
Type of Molecule: Antibodies (and derivatives)
* On clinical hold and working closely with the FDA to resolve their questions
Rare indication
Phase I
Category: Hematology
Type of Molecule: Protein
Rare Indication
Phase III
Category: Hematology
Type of Molecule: Protein
Rare indication
Phase II
Category: Ophthalmics
Type of Molecule: Small Molecule
Rare Indication
2018 Approvals
Category: Hematology
Type of Molecule: Protein
Rare indication
REGISTRATION
Category: Immunology
Type of Molecule: Peptide
Rare indication
Phase III
Category: Immunology
Type of Molecule: Antibodies (and derivatives)
Rare indication
Phase III
Category: Immunology
Type of Molecule: Therapeutic Protein
Rare Indication
Phase III
Category: Hematology
Type of Molecule: Protein
Rare indication
2018 Approvals
Category: Hematology
Type of Molecule: Protein
Rare indication
Phase I
Category: Neuroscience
Type of Molecule: Small Molecule